Skip to content

Celcuity CELC Accounts Payable

Accounts Payable at other companies

Eli Lilly logo
Eli LillyLLY
$5.03B+46.1%
Gilead Sciences logo
Gilead SciencesGILD
$645M-12.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$29.06M+5.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$13.74M-2.9%
CG Oncology logo
CG OncologyCGON
$8.24M+22.4%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$13.65M+4.5%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's accounts payable?
Celcuity (CELC) reported accounts payable of $10.45M in Q1 2026.
How has Celcuity's accounts payable changed year-over-year?
Celcuity's accounts payable increased by 5.3% year-over-year, from $9.93M to $10.45M.
What is the long-term trend for Celcuity's accounts payable?
Over 5 years (2020 to 2025), Celcuity's accounts payable has grown at a 96.7% compound annual growth rate (CAGR), from $217.38K to $6.41M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.